Ulta Beauty (ULTA) Exceeds Market Returns: Some Facts to Consider

Ulta Beauty (ULTA) shares closed at $529.50, marking a 1.79% daily gain and outperforming the S&P 500, extending its recent market outperformance. Ahead of its August 28, 2025 earnings release, analysts project quarterly revenue growth of 3.49% to $2.64 billion, alongside an anticipated 6.23% decline in EPS. ULTA's valuation shows a Forward P/E of 22.09, a premium to its industry's 15.54, while maintaining a Zacks Rank #3 (Hold) despite a recent 0.56% increase in consensus EPS estimates.

Analysis

Ulta Beauty (ULTA) has demonstrated recent stock strength, closing at $529.50 with a 1.79% daily gain and delivering a 1.29% increase over the last month, outperforming both the S&P 500 and its own Retail-Wholesale sector. However, this positive market performance is set against a backdrop of cautious forward-looking estimates ahead of its August 28, 2025 earnings report. Consensus projections indicate a fundamental divergence: revenue is expected to grow 3.49% to $2.64 billion for the quarter and 3.21% for the full year, while earnings per share (EPS) are forecast to decline by 6.23% for the quarter and 7.06% for the full year. This suggests significant potential margin pressure. The stock's valuation reflects this mixed picture, trading at a premium Forward P/E of 22.09 compared to its industry's 15.54, while its PEG ratio of 3.13 is in line with the industry average. Despite the negative EPS growth outlook, consensus EPS estimates have been revised upward by a modest 0.56% in the last 30 days, contributing to its current Zacks Rank of #3 (Hold). The company operates within a relatively strong industry group, ranked in the top 36% by Zacks.

Key Decisions for Investors

• Investors should weigh the company's current stock outperformance against the significant risk posed by projected earnings declines, as the premium forward P/E of 22.09 may be difficult to sustain if margin compression proves to be a persistent trend.
• The upcoming earnings announcement is a critical catalyst; focus should be on management's guidance regarding profitability and cost controls to determine if the projected 6.23% quarterly EPS drop is a temporary issue or a structural shift.
• Given the neutral 'Hold' rating and conflicting signals between positive estimate revisions and negative growth forecasts, maintaining current positions while awaiting earnings clarity is a reasonable strategy, whereas new capital might be better deployed post-announcement or at a more favorable valuation.